Published in Am J Hum Genet on May 14, 2007
Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev (2011) 2.07
Proteomics of the lysosome. Biochim Biophys Acta (2008) 1.68
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis (2010) 1.34
Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum. Curr Neurol Neurosci Rep (2013) 1.18
An extended proteome map of the lysosomal membrane reveals novel potential transporters. Mol Cell Proteomics (2013) 1.13
A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund. Mol Genet Metab (2010) 1.03
A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier. PLoS Genet (2011) 1.02
A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3. Neurobiol Dis (2007) 1.02
Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta (2015) 1.01
Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins. BMC Cell Biol (2009) 0.97
The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking. Clin Lipidol (2012) 0.96
[Diagnostics and treatment of neuronal ceroid lipofuscinoses from the viewpoint of neuropediatricians]. Ophthalmologe (2010) 0.95
S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p. J Cell Sci (2009) 0.93
Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cell Mol Life Sci (2010) 0.93
Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr Pharm Biotechnol (2011) 0.92
Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene. J Med Genet (2012) 0.91
Molecular physiology and pathophysiology of lysosomal membrane transporters. J Inherit Metab Dis (2008) 0.91
A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis. Genes Brain Behav (2011) 0.91
Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis. Neurobiol Dis (2007) 0.88
Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis. Neurobiol Dis (2008) 0.86
A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis. BMC Vet Res (2015) 0.85
Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis. Hum Mol Genet (2010) 0.84
Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL. Neurobiol Dis (2009) 0.84
The Batten disease gene CLN3 is required for the response to oxidative stress. Hum Mol Genet (2011) 0.82
Accumulation of glial fibrillary acidic protein and histone H4 in brain storage bodies of Tibetan terriers with hereditary neuronal ceroid lipofuscinosis. J Inherit Metab Dis (2007) 0.82
The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage. Mol Cell Neurosci (2010) 0.80
A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis. Neurogenetics (2008) 0.79
Neuronal ceroid lipofuscinosis caused by MFSD8 mutations: a common theme emerging. Neurogenetics (2009) 0.79
Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease). Neurochem Int (2009) 0.76
The Novel Membrane-Bound Proteins MFSD1 and MFSD3 are Putative SLC Transporters Affected by Altered Nutrient Intake. J Mol Neurosci (2016) 0.76
Analysis of NCL Proteins from an Evolutionary Standpoint. Curr Genomics (2008) 0.76
Neuronal ceroid lipofuscinosis type CLN2: a new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America. Gene (2012) 0.75
Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis. PLoS One (2014) 0.75
Characteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression. Open Biol (2017) 0.75
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet (2001) 53.16
Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet (2002) 16.29
Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science (1987) 12.20
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Alternative splicing: new insights from global analyses. Cell (2006) 10.31
Major facilitator superfamily. Microbiol Mol Biol Rev (1998) 9.77
A perfect message: RNA surveillance and nonsense-mediated decay. Cell (1999) 7.08
A combined linkage-physical map of the human genome. Am J Hum Genet (2004) 4.60
Ignoring linkage disequilibrium among tightly linked markers induces false-positive evidence of linkage for affected sib pair analysis. Am J Hum Genet (2004) 3.83
Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature (1995) 3.78
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron (2001) 3.51
The isolation and properties of a proteolytic enzyme, cathepsin D, from bovine spleen. Biochem J (1960) 2.94
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain (2006) 2.85
Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell (1995) 2.71
Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science (1997) 2.56
Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J (2005) 1.96
Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet (2006) 1.76
Neuronal ceroid-lipofuscinoses in childhood. Brain Dev (1988) 1.73
Lysosomal targeting of palmitoyl-protein thioesterase. J Biol Chem (1996) 1.67
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet (1999) 1.61
CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet (1998) 1.58
The lactate-proton symport of Saccharomyces cerevisiae is encoded by JEN1. J Bacteriol (1999) 1.55
Kufs' disease: a critical reappraisal. Brain (1988) 1.55
The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol (2003) 1.54
The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am J Hum Genet (2001) 1.52
Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. Proc Natl Acad Sci U S A (2006) 1.44
The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu Rev Neurosci (1997) 1.42
Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest (1998) 1.40
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet (1998) 1.37
Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J (1996) 1.24
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet (2001) 1.21
CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes Cells (2002) 1.20
Families of aspartic peptidases, and those of unknown catalytic mechanism. Methods Enzymol (1995) 1.20
GIT1, a gene encoding a novel transporter for glycerophosphoinositol in Saccharomyces cerevisiae. Genetics (1998) 1.18
CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp Cell Res (2004) 1.10
Glycerophosphocholine-dependent growth requires Gde1p (YPL110c) and Git1p in Saccharomyces cerevisiae. J Biol Chem (2005) 1.10
Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J Biol Chem (2004) 1.04
Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol Cell Biol (2006) 1.02
Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat (2004) 1.02
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum Mol Genet (2000) 0.98
Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum Mol Genet (2002) 0.95
Functional characterization of ORCTL2--an organic cation transporter expressed in the renal proximal tubules. FEBS Lett (1998) 0.89
Functional expression of the lactate permease Jen1p of Saccharomyces cerevisiae in Pichia pastoris. Biochem J (2003) 0.89
Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: Another genetic hit in the Mediterranean. Neurogenetics (2006) 0.88
Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr (2004) 0.88
Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin. Clin Genet (2005) 0.86
Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann Neurol (2004) 0.86
A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7. Mol Genet Metab (1999) 0.82
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol (2011) 18.34
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol (2008) 4.07
Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol (2005) 3.99
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes (2009) 3.16
Somatic mutations in cerebral cortical malformations. N Engl J Med (2014) 3.13
Human chromosome 7: DNA sequence and biology. Science (2003) 3.02
Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat Genet (2004) 3.01
WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med (2013) 2.91
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain (2006) 2.85
Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull (2003) 2.76
Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet (2010) 2.74
Cadherin-directed actin assembly: E-cadherin physically associates with the Arp2/3 complex to direct actin assembly in nascent adhesive contacts. Curr Biol (2002) 2.74
Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist (2003) 2.69
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet Epidemiol (2006) 2.45
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
Dimensions of religiosity and their relationship to lifetime psychiatric and substance use disorders. Am J Psychiatry (2003) 2.32
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut (2011) 2.26
Identification of genomic regions associated with phenotypic variation between dog breeds using selection mapping. PLoS Genet (2011) 2.24
Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat (2011) 2.13
Retracted VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification. Cell (2009) 2.11
A mutation in hairless dogs implicates FOXI3 in ectodermal development. Science (2008) 2.06
The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet (2005) 2.05
Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet (2003) 2.00
Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet (2003) 1.96
Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc Natl Acad Sci U S A (2007) 1.89
The GENCODE exome: sequencing the complete human exome. Eur J Hum Genet (2011) 1.88
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet (2004) 1.88
Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem (2008) 1.86
Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet (2003) 1.83
Brain dopamine-serotonin vesicular transport disease and its treatment. N Engl J Med (2013) 1.79
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet (2011) 1.77
Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization. J Cell Biol (2004) 1.74
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest (2013) 1.74
Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology (2005) 1.70
Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts. J Cell Sci (2006) 1.68
CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa. Am J Hum Genet (2008) 1.67
Mutations in prickle orthologs cause seizures in flies, mice, and humans. Am J Hum Genet (2011) 1.60
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet (2013) 1.59
Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am J Med Genet B Neuropsychiatr Genet (2011) 1.58
Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes (2008) 1.56
Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. Am J Hum Genet (2012) 1.54
Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet (2005) 1.52
Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity. J Biol Chem (2004) 1.50
Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex. Nat Genet (2010) 1.49
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48
CRYBA4, a novel human cataract gene, is also involved in microphthalmia. Am J Hum Genet (2006) 1.41
Glycogen hyperphosphorylation underlies lafora body formation. Ann Neurol (2010) 1.41
Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc Natl Acad Sci U S A (2009) 1.40
De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet (2013) 1.40
Phosphorylation prevents polyglucosan transport in Lafora disease. Neurology (2012) 1.39
Expanded repeat in canine epilepsy. Science (2005) 1.37
Genotype-phenotype analysis of human frontoparietal polymicrogyria syndromes. Ann Neurol (2005) 1.37
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol (2007) 1.36
USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet (2002) 1.36
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35
PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet (2011) 1.35
Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes (2007) 1.34
VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy. Acta Neuropathol (2013) 1.34
Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes (2005) 1.34
Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet (2012) 1.33
Delineation of Cohen syndrome following a large-scale genotype-phenotype screen. Am J Hum Genet (2004) 1.31
Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Hum Mol Genet (2004) 1.30
BR-squared: a practical solution to the winner's curse in genome-wide scans. Hum Genet (2011) 1.28
Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One (2009) 1.28
A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients. J Exp Clin Cancer Res (2011) 1.27
Genome-wide analysis reveals selection for important traits in domestic horse breeds. PLoS Genet (2013) 1.26
Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biol Psychiatry (2008) 1.26
Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. Hum Mol Genet (2013) 1.26
Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke (2003) 1.25
Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol (2009) 1.24
Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol (2009) 1.23
Type 1 diabetes in the BB rat: a polygenic disease. Diabetes (2009) 1.21
Incidence of sudden cardiac death in China: analysis of 4 regional populations. J Am Coll Cardiol (2009) 1.19
A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiol Dis (2011) 1.19
Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol (2003) 1.18
Genetic diversity in the modern horse illustrated from genome-wide SNP data. PLoS One (2013) 1.18
Stepwise formation of a SMAD activity gradient during dorsal-ventral patterning of the Drosophila embryo. Development (2003) 1.17
Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Ann Neurol (2010) 1.17
LUPA: a European initiative taking advantage of the canine genome architecture for unravelling complex disorders in both human and dogs. Vet J (2011) 1.15
Molecular genetics of the NCLs -- status and perspectives. Biochim Biophys Acta (2006) 1.15
LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genet (2011) 1.14
Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy. Hum Mutat (2004) 1.13
Were genome-wide linkage studies a waste of time? Exploiting candidate regions within genome-wide association studies. Genet Epidemiol (2010) 1.12